Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Mycosis fungoides and CD30+ cutaneous T-cell lymphoma simulating pyoderma gangrenosum in a patient with ulcerative colitis

VIEWS: 30 PAGES: 5

A global leader in serving libraries of all types, ProQuest LLC (“ProQuest”) supports the breadth of the information community with innovative discovery solutions that power the business of books and the best in research experience. More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others.

More Info
  • pg 1
									DOI: 10.3315/jdcr.2009.1030                                                                                           30




Mycosis fungoides and CD30+ cutaneous T-cell lymphoma
simulating pyoderma gangrenosum in a patient with ulcerative
colitis
Fares Salameh, Aviv Barzilai, Sharon Baum, Henri Trau

Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv
University, Israel



Corresponding author:                    Abstract
Fares Salameh M.D.
                                           Background: Pyoderma gangrenosum is estimated to occur in 5% to 12% of
Department of Dermatology                ulcerative colitis patients. Primary CD30+ cutaneous large cell lymphoma is the
                                         second most common cutaneous lymphoma. It may coexists with mycosis fungo-
The Chaim Sheba Medical Center,
                                         ides.
Tel Hashomer 52621 Israel
                                           Main observations: We report a 38-years-old female patient with 12 year histo-
E-mail: faressalameh@hotmail.com         ry of ulcerative colitis, treated previously with 5-aminosalicylic acid and systemic
                                         corticosteroids. The disease has been in remission for the past 1.5 years, with no
                                         maintenance treatment. The patient then developed a rapidly progressing ulcera-
Key words:                               ted lesion clinically simulating pyoderma gangrenosum. Physical examination re-
cutaneous T-cell lymphoma, in-           vealed also a small number of hairless hypopigmented patches on the upper and
flammatory bowel disease, myco-          lower limbs which she claimed to have appeared 4 years ago. Surprisingly a histo-
sis fungoides, ulcer, ulcerative coli-   logical evaluation of the ulcer revealed a CD30+ primary cutaneous large cell
tis, pyoderma gangrenosum                lymphoma, while histology of hypopigmented lesions revealed mycosis fungoides,
                                         patch stage. T-cell receptor gene rearrangement from the two lesions didn't reveal
                                         the same T Cell clonalitiy and the patients lymphoma was stable.
                                           Conclusion: Our case presents the rare coexistence of primary mycosis fungo-
                                         ides and primary CD30+ cutaneous large cell lymphoma, rather than the CD30+
                                         cutaneous large cell lymphoma developing from mycosis fungoides. This case also
                                         presents the development of a pyoderma gangrenosum-like lesion of CD30+ cu-
                                         taneous large cell lymphoma in a patient with ulcerative colitis. An observation
                                         that emphasizes the need for a high index of suspicion in cases diagnosed as py-
                                         oderma gangrenosum based solely on clinical appearance.




Introduction                                                    PCLCL was reported to coexist with MF as an indepen-
                                                                dent lymphoproliferative disorder or develop secondarily
   Primary cutaneous T-cell lymphoma (CTCL) represents          from MF.4,5,6,7,8
a heterogeneous group of neoplasms derived from skin-             We describe a patient with MF patch stage coexisting
homing T cells. Apart from mycosis fungoides (MF), pri-         with CD30+ PCLCL presenting as a pyoderma gangreno-
mary CD30+ CTCL is the most common group, accoun-               sum (PG) like lesion.
ting for approximately 25% of all CTCLs.1 The spectrum of
primary CD30+ CTCLs includes lymphomatoid papulosis
(LyP), primary cutaneous large cell lymphoma (PCLCL),           Case report
and borderline CD30+ lesions.2 These three types may
coexist in the same patient with overlapping clinical and          A 38-years-old woman with a 12 years history of ulcera-
histopathological features and may be associated with           tive colitis was admitted to our department for an investi-
other types of lymphoproliferative disorders including          gation of a rapidly progressing ulcerated lesion on her
Hodgkin’s lymphoma and mycosis fungoides (MF).3 CD30+           right thigh which appeared 9 days previously. Ulcerative


                                                                                         J Dermatol Case Rep 2009 2, pp 30-33
								
To top